close
close

Cymbalta bottle recall; Suicide rates highest on Mondays; New dose of painkiller OK

Cymbalta bottle recall; Suicide rates highest on Mondays; New dose of painkiller OK

Over 7,000 bottles of this drink the antidepressant duloxetine (Cymbalta) was withdrawn. due to the potential presence of a carcinogenic substance. (USA today)

Psychosocial well-being prior to trauma can help protect against: development of post-traumatic stress disorder– say researchers in JAMA network open.

In a study conducted in 26 countries and territories suicide risk was highest on Mondays and increases on New Year’s Day in most areas. (BMJ)

Suicide-related emergencies are underdetected According to a review of data from electronic health records, in adolescents and adolescents from national minorities. (JAMA network open)

Preliminary biomarker results from an ongoing Phase II trial schizophrenia drug ANAVEX3-71 showed dose-dependent improvements in neural synchrony, thalamocortical circuits and sensory gating, claims Anavex Life Sciences.

FDA approved oxycodone hydrochloride (Roxybond) 10 mg immediate-release tablets with abuse-deterrent technology for the treatment of severe pain for which alternative treatments have proven inadequate, Protega Pharmaceuticals announced.

Can digital “avatars” be effective? treatment of psychosis? (STAT)

AND Lancet Public Health Commission for gambling required regulatory reform to address the health consequences of commercial gambling.

The panel will check it alleged cases of abuse and neglect at the Psychiatric Institute in Washington. (Washington Post Office)

What happened to the American study suggesting puberty blockers did not improve the mental health of children with gender-related disorders? (New York Times)

  • author('name and surname')

    Kristen Monaco is a senior writer focusing on news in endocrinology, psychiatry and nephrology. He lives in the New York office and has been with the company since 2015.